B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

January 16, 2021
Open Access

Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response

Cancers
Mirco Di MarcoRosa Visone
January 12, 2021
Case Report

Mandibular non-Hodgkin's lymphoma: two observations of a challenging disease

The Pan African Medical Journal
Yassine OueslatiNabiha Douki
January 12, 2021
Open Access

Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression

Frontiers in Immunology
Yifei LiuJiahai Shi
January 17, 2021
Open Access

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

Journal of Hematology & Oncology
Janek S WalkerRosa Lapalombella
January 16, 2021

Axicabtagene ciloleucel and brexucabtagene autoleucel in relapsed and refractory diffuse large B-cell and mantle cell lymphomas

Future Oncology
Patrick M Reagan, Jonathan W Friedberg
January 13, 2021
Open Access

CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cells

Nature Communications
Mario BunseUta E Höpken
January 15, 2021

Vaccinations in CLL: implications for COVID-19

Blood
Mazyar Shadman, Chaitra Ujjani
January 14, 2021

Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada

Current Oncology
Jean LachaineCarolyn Owen
January 15, 2021

The role of IL4I1 in immunoregulation: An update

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Wenqian LiuXiangrong Liu
January 13, 2021
Correction
Open Access

Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371

Experimental Cell Research
Chong WangShujuan Wang
January 13, 2021

Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment

International Journal of Laboratory Hematology
Gaurav ChatterjeePrashant R Tembhare
January 14, 2021

A Systematic Review of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Engaging an Old Problem With New Solutions

The Annals of Pharmacotherapy
Zachery HalfordTabitha Brown
January 15, 2021

The subgroup of 2'-hydroxy-flavonoids: Molecular diversity, mechanism of action, and anticancer properties

Bioorganic & Medicinal Chemistry
Christian Bailly
January 17, 2021

A bispecific single domain antibody boosts autologous Vγ9Vδ2-T cell responses towards CD1d in chronic lymphocytic leukemia

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Iris de WeerdtHans J van der Vliet
January 14, 2021

Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database

Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques
Mayako UchidaYoshihiro Uesawa
January 13, 2021
Open Access

Combinatorial CAR design improves target restriction

The Journal of Biological Chemistry
Hakan KöksalSébastien Wälchli

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2021 Meta ULC. All rights reserved
/feed-previews/b-cell-leukemia-keystone/e5e66ccc-f234-4039-b472-004df1364d28